L-proline and L-pipecolate induce enkephalin-sensitive currents in human embryonic kidney 293 cells transfected with the high-affinity mammalian brain L-proline transporter
A. Galli et al., L-proline and L-pipecolate induce enkephalin-sensitive currents in human embryonic kidney 293 cells transfected with the high-affinity mammalian brain L-proline transporter, J NEUROSC, 19(15), 1999, pp. 6290-6297
The high-affinity mammalian brain L-proline transporter (PROT) belongs to t
he GAT1 gene family, which includes Na- and Cl-dependent plasma membrane ca
rriers for neurotransmitters, osmolites, and metabolites. These transporter
s couple substrate flux to transmembrane electrochemical gradients, particu
larly the Na gradient. In the nervous system, transporters clear synapses a
nd help to replenish transmitters in nerve terminals. The localization of P
ROT to specific excitatory terminals in rat forebrain suggests a role for t
his carrier in excitatory transmission (Renick et al., 1999). We investigat
ed the voltage regulation and electrogenicity of this novel transporter, us
ing human embryonic kidney (HEK) 293 cells stably transfected with rat PROT
cDNA. In physiological solutions between -140 and -40 mV, L-proline (PRO)
and its six-member ring congener (PIP) induced inward current. The current-
voltage relationship of PROT or in an externally accessible pore. and the v
ariance of current fluctuations were similar for PRO- and PIP-induced curre
nt, and the ratio of induced variance to the mean current ranged from 20 to
60 fA, Des-Tyr-Leu-enkephalin (GGFL), a competitive peptide inhibitor of P
ROT, reduced the rat PROT-associated current to control levels. GGFL alone
did not elicit currents, and the GGFL-sensitive substrate-induced current w
as absent in nontransfected cells. Finally, GGFL inhibited PROT-mediated tr
ansport only when applied to the extracellular face of PROT. These data sug
gest that (1) PROT uptake is electrogenic, (2) individual transporter curre
nts are voltage-independent, and (3) GGFL is a nonsubstrate inhibitor that
interacts either with an extracellular domain of PROT or in an externally a
ccessible pore.